Literature DB >> 9990636

Initial experience with a new balloon-guided single lead catheter for internal cardioversion of atrial fibrillation and dual chamber pacing.

A Plewan1, C Valina, R Herrmann, E Alt.   

Abstract

BACKGROUND: Based on the observation that internal cardioversion (IntCV) of atrial fibrillation is effective with electrodes in the right atrium and pulmonary artery, a new balloon-guided catheter and external defibrillation device with optional dual chamber pacing was evaluated.
METHODS: IntCV was attempted in 27 patients (age: 57 +/- 10 years, duration: 14 +/- 18 months, left atrial diameter 56 +/- 8 mm) using a new defibrillation device (Alert, EP MedSystems, Inc., NJ, USA) that allows the delivery of biphasic shocks (0.5-15 J, variable tilt), atrial and ventricular pacing, and online signal recording. Pacing and defibrillation shocks were applied via a 7.5 Fr balloon-guided catheter (EP MedSystems, Inc.). Pacing, sensing, and triggering were established through the proximal atrial array and an electrode ring between both defibrillation arrays and a single ventricular electrode ring. Catheters were inserted from the antecubital vein.
RESULTS: In 25 of 27 patients sinus rhythm was restored with a mean energy of 6.7 +/- 4.5 J. In five patients, atrial postshock pacing was required for bradycardia and atrial premature beats. The mean fluoroscopy time was 2.0 +/- 1.3 minutes.
CONCLUSION: The high success rate, ease of application, and backup dual chamber pacing suggest that this system is an alternative to established methods of cardioversion. In certain indications, such as failure of prior external cardioversion and situations in which a standard pulmonary balloon catheter is needed, this system would be advantageous.

Entities:  

Mesh:

Year:  1999        PMID: 9990636     DOI: 10.1111/j.1540-8159.1999.tb00338.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  Transvenous low energy internal cardioversion for atrial fibrillation refractory to external cardioversion: do non-obese patients benefit?

Authors:  D Pavin; H Legrand; C Leclercq; C Crocq; P Mabo; J C Daubert
Journal:  Heart       Date:  2004-03       Impact factor: 5.994

2.  Initial experience with single lead intracardial cardioversion for refractory atrial fibrillation.

Authors:  H A van de Klippe; C P Allaart; J H Ruiter
Journal:  Neth Heart J       Date:  2001-09       Impact factor: 2.380

3.  Current status of internal cardioversion in atrial fibrillation.

Authors:  Andreas Plewan; Eckhard Alt
Journal:  Indian Pacing Electrophysiol J       Date:  2002-04-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.